LIAONING CHENG DA BIOTECHNOLOGY financial statements, including revenue, expenses, profit, and loss
The total revenue of 688739 for the last quarter is 416.40 M CNY, and it's 18.35% lower compared to the previous quarter. The net income of Q3 24 is 109.48 M CNY.